Epithelium/imcDC2 axis facilitates the resistance of neoadjuvant anti-PD-1 in human NSCLCYongyuan Chen, Pin Wu, Di Chen et al.|Journal for ImmunoTherapy of Cancer|2024Cited by 15
The clinical characteristics and prognostic factors of 410 patients with natural killer/T-cell lymphomaZhenchang Sun, Mingzhi Zhang, Wenjuan Wan et al.|Journal of Cancer Research and Clinical Oncology|2022Cited by 11
PD‐1 Inhibits CD4+ TRM‐Mediated cDC1 Mobilization via Suppressing JAML in Human NSCLCZheyu Shao, Pin Wu, Qinyuan Liu et al.|Advanced Science|2026Cited by 0